Organic Pharmaceutical Excipients Market Report 2026

Organic Pharmaceutical Excipients Market Overview

• Organic Pharmaceutical Excipients market size has reached to $12.21 billion in 2025 • Expected to grow to $18.99 billion in 2030 at a compound annual growth rate (CAGR) of 9.3% • Growth Driver: The Rising Demand For Pharmaceutical Drugs Is Driving The Market Due To Expanding Therapeutic Needs And Advancing Treatment Development • Market Trend: Label-Friendly Excipients Transforming The Organic Pharmaceutical Excipients Market • North America was the largest region in 2025.

What Is Covered Under Organic Pharmaceutical Excipients Market?

Organic pharmaceutical excipients refer to substances of natural origin used in formulating pharmaceutical products alongside active pharmaceutical ingredients (APIs). They are derived from natural sources, such as plants, animals, or microorganisms, and are generally considered safe for pharmaceutical applications. The main types of organic pharmaceutical excipients are oleochemicals, carbohydrates, petrochemicals, proteins, and others. Oleochemicals are a group of chemicals derived from oils and fats and used in a wide variety of products, including soaps, detergents, cosmetics, lubricants, and biodiesel. They function as binding agents, coating agents, colorants, disintegrants, and other functions used in oral formulations, topical formulations, parenteral formulations, and others.

What Is The Organic Pharmaceutical Excipients Market Growth Forecast?

The organic pharmaceutical excipients market size is expected to see strong growth in the next few years. It will grow to $18.99 billion in 2030 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to expansion of biopharmaceutical pipelines, rising demand for sustainable drug formulations, increasing focus on patient-centric formulations, advancements in excipient processing technologies, stricter regulations favoring non-toxic excipients. Major trends in the forecast period include growing preference for plant-based and naturally derived excipients, rising demand for clean-label and non-toxic pharmaceutical ingredients, increased adoption of organic excipients in oral solid dosage forms, expansion of functional excipients enhancing drug stability and bioavailability, rising regulatory support for naturally sourced pharmaceutical additives.

Global Organic Pharmaceutical Excipients Market Segmentation

1) By Type: Oleochemicals, Carbohydrates, Protein, Other Types 2) By Functions: Binders, Coating Agents, Colorants, Disintegrates, Other Functions 3) By Application: Oral Formulations, Topical Formulations, Parenteral Formulations, Other Applications Subsegments: 1) By Oleochemicals: Fatty Acids, Glycerin, Fatty Alcohols, Surfactants, Esters 2) By Carbohydrates: Starch, Cellulose, Dextrins, Sugars, Pectins 3) By Protein: Gelatin, Albumin, Collagen, Casein, Whey Protein 4) By Other Types: Natural Excipients, Inorganic Excipients, Microcrystalline Cellulose

What Is The Driver Of The Organic Pharmaceutical Excipients Market?

The rising demand for pharmaceutical drugs is expected to fuel the growth of the organic pharmaceutical excipients market going forward. Pharmaceutical drugs are scientifically formulated substances used to diagnose, treat, prevent, or manage diseases by interacting with specific biological pathways to restore or maintain physiological function. A primary factor driving the rising demand for pharmaceutical drugs is the growing burden of complex and chronic health conditions, which necessitates continuous therapeutic intervention and encourages the development of more advanced, targeted, and accessible treatment options to support long-term patient care. Organic pharmaceutical excipients support this increasing demand by enhancing drug stability, delivery, and bioavailability, thereby enabling the efficient formulation and performance of a wide range of modern medications. For instance, in January 2024, according to the New Drug Therapy Approvals 2023 report published by the Center for Drug Evaluation and Research (CDER), a US-based branch of the U.S. Food and Drug Administration (FDA), the CDER approved 55 novel drugs in 2023, with 20 (36%) identified as first-in-class, compared to 37 novel drug approvals in 2022. Therefore, the rising demand for pharmaceutical drugs is driving the growth of the organic pharmaceutical excipients industry.

Key Players In The Global Organic Pharmaceutical Excipients Market

Major companies operating in the organic pharmaceutical excipients market are Roquette Frères SA, DuPont de Nemours Inc., Ashland Inc., Kerry Group plc, Evonik Industries AG, Croda International plc, Innophos Holdings Inc., Wacker Chemie AG, Merck KGaA, Colorcon Asia Private Limited, JRS PHARMA GMBH + CO KG, Cargill Incorporated, Ingredion Incorporated, Sensient Technologies Corporation, Lonza Group Ltd., DFE PHARMA INDIA PRIVATE LIMITED., Omya AG, Sigachi Industries Pvt. Ltd., Meggle AG, Archer Daniels Midland Company

Global Organic Pharmaceutical Excipients Market Trends and Insights

Major companies in the organic pharmaceutical excipients market are focusing on developing innovative products such as label-friendly excipient systems to meet evolving formulation needs, enhance product transparency, and support clean-label initiatives in health-related consumer markets. A label-friendly excipient system refers to a formulation-support material derived from natural or organic sources that enables safe, stable, and effective drug or supplement manufacturing while aligning with consumer preferences for minimal, recognizable, and non-synthetic ingredients. For instance, in April 2023, Colorcon, a US-based pharmaceutical excipient provider, launched Nutracore, an innovative range of label-friendly excipients tailored to the specific requirements of nutraceutical and supplement providers. These excipients are crafted from natural and organic materials to meet the growing demand for clean labeling in the nutritional and dietary supplement industry while ensuring optimal manufacturability and performance. Nutracore excipients enable manufacturers to meet consumers' label-friendly expectations without compromising on the quality and functionality of their products.

What Are Latest Mergers And Acquisitions In The Organic Pharmaceutical Excipients Market?

In May 2025, Roquette, a France-based provider of plant-based ingredients and pharmaceutical excipients, acquired IFF Pharma Solutions for an undisclosed amount. With this acquisition, Roquette aims to strengthen its global pharmaceutical excipient capabilities by integrating IFF Pharma Solutions’ advanced drug-delivery technologies to expand its product portfolio and accelerate growth in high-value formulation markets. IFF Pharma Solutions is a US-based provider of pharmaceutical excipients, drug-delivery polymers, and specialized formulation technologies.

Regional Insights

North America was the largest region in the global organic pharmaceutical excipients market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Organic Pharmaceutical Excipients Market?

The organic pharmaceutical excipient market consists of sales of starch, cellulose, hydroxypropyl methylcellulose, and polyvinylpyrrolidone. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Organic Pharmaceutical Excipients Market Report 2026?

The organic pharmaceutical excipients market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the organic pharmaceutical excipients industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.